Association between IADAM33/I Single-Nucleotide Polymorphisms and Treatment Response to Inhaled Corticosteroids and a Long-Acting Beta-Agonist in Asthma

• Published in: Diagnostics (Basel) 2023-01, Vol.13 (3)
• Main Authors: Vishweswaraiah, Sangeetha, Ramachandra, Nallur B, Joshi, Neha, Parthasarathi, Ashwaghosha, Kaleem Ullah, Mohammed, Siddaiah, Jayaraj Biligere, Holla, Amrutha D, Chakraborty, Samarpana, Agrawal, Anurag, Mahesh, Padukudru Anand
• Format: Article
• Language: English
• Subjects: Adrenergic beta agonists; Asthma; Corticosteroids; Dosage and administration; Drug therapy; Genetic aspects; Health aspects; Patient outcomes; Single nucleotide polymorphisms
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics13030405

ADAM33 has been linked to airway structural changes in patients with asthma, leading to airway hyperresponsiveness, narrowing, and ultimately poor treatment responsiveness. This study aimed to evaluate the genetic association of ADAM33 SNPs with asthma, disease severity, and treatment responsiveness to ICS+LABA in the South Indian population. In this case–control study (486 controls and 503 cases), we performed genotyping using MassArray for six SNPs of ADAM33, namely rs2280091, rs2787094, rs3918396, rs67044, rs2853209, and rs3918392. We studied the association with asthma and treatment responsiveness to ICS+LABA, using genotype, allele frequency distribution, and haplotype analysis. A significant clinical finding of the study was that certain patients in the disease severity group (moderate and mild) showed poor or no improvement after a three-month follow-up of regular ICS+LABA therapy. Of the studied ADAM33 SNPs, rs2853209 showed an association with asthma. The further analysis of asthma patients according to disease severity suggested an association between moderate disease and the minor allele “T” for rs2853209. The homozygous minor allele of SNP rs2787094 was found to be associated with poorer lung function and the least lung-function improvement after three months of ICS+LABA therapy. The haplotype analysis of six SNPs showed a significant association between the rs2853209 and rs3918396 blocks and asthma. ADAM33 gene polymorphism has clinical relevance in terms of disease association and response to treatment. SNP rs2853209 seemed most relevant to asthma, and SNP rs2787094 could be a genetic marker for predicting response to ICS+LABA therapy in the study population.